Oxurion Temporarily Suspends Investment in Crypto-Assets

Oxurion NV, a pharmaceutical outsourcing company based in Leuven, Belgium, has announced a temporary suspension of its investment program in digital assets and crypto-assets. This decision follows the review of the project's viability under current market conditions. The initiative, initially revealed in December 2025, aimed to explore alternative asset classes similar to existing financial investments.

Due to significant volatility in crypto markets, alongside economic and geopolitical uncertainties, Oxurion has decided to defer this investment. The company stated that necessary conditions for disbursing the first tranche of financing remain unmet, meaning no funds have been utilized.

This adjustment does not alter Oxurion's business model or core activities. The company remains focused on its growth and acquisition strategies and will update the market on future developments.